The Honourable Dalton McGuinty, Premier of Ontario, Canada, to Receive BIO International Leader Award

WASHINGTON, D.C. (Wednesday, May 06, 2009) - The Honourable Dalton McGuinty, Premier of Ontario, Canada., will receive the Biotechnology Industry Organization’s (BIO) second annual International Leadership Award for his strong commitment to the development and growth of the biotechnology industry in Ontario, Canada.


The award honours individuals who have shown a strong commitment to advancing biotechnology through policy mechanisms that facilitate and strengthen a country or region’s innovation frameworks.  The award will be presented to the Honourable Dalton McGuinty at the 2009 BIO International Convention.


“Premier McGuinty was chosen for this award based on his exemplary record of promoting the biotechnology industry and innovation in the life sciences in Ontario,” said James C. Greenwood, president and CEO, BIO.  “I strongly believe that our industry will continue to thrive in Ontario under his leadership.”


“I want to thank the Biotechnology Industry Organization for this great honour,” said Premier McGuinty.  “Every day, researchers in Ontario are building on our strong reputation for leadership in the life sciences. It's their hard work that's led to discoveries with the power to transform lives and our economy. Our government will continue to fund their efforts so Ontario is the home of the next generation of breakthroughs, the next generation of businesses and the next generation of jobs."


"Premier McGuinty has shown strong leadership and a commitment to innovation and biotechnology," said Peter Brenders, President and CEO of BIOTECanada, Canada's national association representing the biotechnology sector. "BIOTECanada has seen clear support for the commercialization of biotechnology and life sciences innovations in the past year and we believe work Premier McGuinty has begun is escalating Ontario into a global biotechnology hub." 


Under McGuinty’s leadership, Ontario has pledged over $3.2-billion dollars to support research and innovation through Ontario’s Innovation Agenda; the creation of the Ontario Institute for Cancer Research; programs such as Ontario’s Biopharmaceutical Investment Program; clean fuel initiatives; and programs to support talent retention and R&D -- including a new $100-million competition for genomics and gene-related research: The Global Leadership Round in Genomics and Life Sciences.


In 2005, McGuinty first led a group of business and researcher representatives to the 2005 BIO International Convention in Philadelphia, signaling the start of great growth in Ontario’s biotech industry. 

With 25 research and academic hospitals employing 10,000 scientists, clinical investigators and other researchers conducting $850 million in research annually, Ontario is the largest hub of biomedical activity in Canada and the third largest biomedical research centre in North America.

Ontario’s life sciences industry employs more than 43,000 people at more than 850 companies which generate more than $14 billion in annual revenues.

Each year, the BIO International Convention draws industry leaders from approximately 48 states and 60 countries.  This year, the Convention program will feature 167 sessions in 22 breakout session tracks.  Sessions will address the most pressing issues facing biotech today, including healthcare pricing and access, capital formation and partnering strategies in a tight credit environment, and climate change and biofuels.

In addition, this year’s BIO Exhibition will cover will cover an estimated 176,000 net sq. ft. and host more than 1,800 exhibitors.
To register for the BIO International Convention, please visit  

Advanced media registration will be available online through May 8, 2009.  To register, please visit

The BIO International Convention helps to support BIO programs and initiatives.  BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.  For more information on the global event for biotechnology, including program and housing information, please visit  

2009 BIO International Convention Social tagging & Social Media

Be included in official convention coverage: Tag your convention related content, blog posts, photos and videos with bio09

Twitter with us: hashtag #bio09

Follow us on Twitter:

Listen to our podcasts:

Join us on FaceBook:

Connect with us on LinkedIn:

Visit our YouTube channel:

View our photo albums on Flickr:

Upcoming BIO Events

BIO-LES Business Development Basics Course
May 15–17, 2009
Atlanta, GA  

BIO-LES Advanced Business Development Course
May 15–17, 2009
Atlanta, GA 

BIO Executive Presentation Workshop
May 17, 2009
Atlanta, GA

BIO Human Resources Conference
May 17-19, 2009
Atlanta, GA

2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.

BioEquity Europe
June 9-10, 2009
Munich, Germany

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.